Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela Melegh

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Genome Medicine|September 14, 2010
Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learnedAnita Maasz, Bela Melegh
Nutrition & Diabetes|March 18, 2018
Role of carnitine and its derivatives in the development and management of type 2 diabetesJudit Bene, Kinga Hadzsiev, Bela Melegh
Current Medicinal Chemistry|August 13, 2016
Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the LiteratureRenata Szalai, Kinga Hadzsiev, Bela Melegh
Current Molecular Medicine|November 16, 2019
Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine HomeostasisJudit Bene, Andras Szabo, Katalin Komlósi, et al.
Molecular Biology Reports|October 10, 2014
Significant interethnic differencies in functional variants of PON1 and P2RY12 genes in Roma and Hungarian population samplesIngrid Janicsek, Csilla Sipeky, Judit Bene, et al.
International Urology and Nephrology|June 12, 2012
Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patientsBotond Csiky, Judit Bene, Istvan Wittmann, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 4, 2011
Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysisJudit Bene, Botond Csiky, Katalin Komlosi, et al.
Autoimmune Diseases|December 16, 2010
Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G AlleleBernadett Farago, Peter Kisfali, Lili Magyari, et al.
Environmental Toxicology and Pharmacology|October 22, 2017
CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in HungaryReka Varnai, Csilla Sipeky, Lajos Nagy, et al.
Renal Failure|March 16, 2012
Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patientsJudit Bene, Botond Csiky, Istvan Wittmann, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Genome Medicine|September 14, 2010
Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learnedAnita Maasz, Bela Melegh
Nutrition & Diabetes|March 18, 2018
Role of carnitine and its derivatives in the development and management of type 2 diabetesJudit Bene, Kinga Hadzsiev, Bela Melegh
Current Medicinal Chemistry|August 13, 2016
Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the LiteratureRenata Szalai, Kinga Hadzsiev, Bela Melegh
Current Molecular Medicine|November 16, 2019
Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine HomeostasisJudit Bene, Andras Szabo, Katalin Komlósi, et al.
Molecular Biology Reports|October 10, 2014
Significant interethnic differencies in functional variants of PON1 and P2RY12 genes in Roma and Hungarian population samplesIngrid Janicsek, Csilla Sipeky, Judit Bene, et al.
International Urology and Nephrology|June 12, 2012
Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patientsBotond Csiky, Judit Bene, Istvan Wittmann, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 4, 2011
Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysisJudit Bene, Botond Csiky, Katalin Komlosi, et al.
Autoimmune Diseases|December 16, 2010
Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G AlleleBernadett Farago, Peter Kisfali, Lili Magyari, et al.
Environmental Toxicology and Pharmacology|October 22, 2017
CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in HungaryReka Varnai, Csilla Sipeky, Lajos Nagy, et al.
Renal Failure|March 16, 2012
Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patientsJudit Bene, Botond Csiky, Istvan Wittmann, et al.
Pageof 10